FDA targets oversight of 3D printed medical devices in point-of-care

By Stewart Eisenhart, Emergo Group

A new dialogue paper from the US Food and Drug Administration identifies issues to developing effective regulatory oversight of 3D printed professional medical units applied in individual point of care (PoC) configurations, and lays out opportunity regulatory approaches for this sort of devices.

Get the total tale listed here at the Emergo Group’s blog.

The viewpoints expressed in this site article are the author’s only and do not always reflect all those of MedicalDesignandOutsourcing.com or its staff.

Resource hyperlink